This statistic illustrates the expenditure of AbbVie on research and development as a percentage of revenue from 2012 to 2023. In 2024, AbbVie spent some 23 percent of its revenue on research and development.
Abbot was a U.S.-based global pharmaceutical and healthcare products company, headquartered in Chicago, Illinois. In January 2013, Abbott was separated into two companies: Abbott Laboratories and AbbVie. Abbott Laboratories is now specialized on medical products, while AbbVie is responsible for research-based pharmaceuticals. On May 8, 2020, AbbVie completed the acquisition of Allergan plc.
AbbVie's research and development spending as a share of revenue from 2012 to 2024
(in million U.S. dollars)
Characteristic
R&D spending as share of revenue
2024
23%
2023
14%
2022
11%
2021
12%
2020
14%
2019
19%
2018*
32%
2017
18%
2016
17%
2015
19%
2014
17%
2013
15%
2012
15%
0%5%10%15%20%25%30%35%40%
Add this content to your personal favorites. These can be accessed from the favorites menu in the main navigation.
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
This statistic was assembled from several of Abbvie's annual reports. * Research and development expenses in 2018 increased from 2017 principally due to a $5.1 billion intangible asset impairment charge related to IPR&D acquired as part of the 2016 Stemcentrx acquisition following the decision to stop enrollment in the TAHOE trial.
** R&D expenses for 2024 were impacted by the intangible asset impairment charge of $4.5 billion related to emraclidine compared to an intangible asset impairment charge of $630 million in 2023, increased funding to support all stages of the company's pipeline assets and acquisition and integration costs incurred in connection with the ImmunoGen and Cerevel Therapeutics acquisitions including cash-settled, post-closing expense for employee incentive awards.
Learn more about how Statista can support your business.
AbbVie, & U.S. Securities and Exchange Commission. (February 14, 2025). AbbVie's research and development spending as a share of revenue from 2012 to 2024 (in million U.S. dollars) [Graph]. In Statista. Retrieved May 14, 2025, from https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie, und U.S. Securities and Exchange Commission. "AbbVie's research and development spending as a share of revenue from 2012 to 2024 (in million U.S. dollars)." Chart. February 14, 2025. Statista. Accessed May 14, 2025. https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie, U.S. Securities and Exchange Commission. (2025). AbbVie's research and development spending as a share of revenue from 2012 to 2024 (in million U.S. dollars). Statista. Statista Inc.. Accessed: May 14, 2025. https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie, and U.S. Securities and Exchange Commission. "Abbvie's Research and Development Spending as a Share of Revenue from 2012 to 2024 (in Million U.S. Dollars)." Statista, Statista Inc., 14 Feb 2025, https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
AbbVie & U.S. Securities and Exchange Commission, AbbVie's research and development spending as a share of revenue from 2012 to 2024 (in million U.S. dollars) Statista, https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/ (last visited May 14, 2025)
AbbVie's research and development spending as a share of revenue from 2012 to 2024 (in million U.S. dollars) [Graph], AbbVie, & U.S. Securities and Exchange Commission, February 14, 2025. [Online]. Available: https://www.statista.com/statistics/807898/r-and-d-expenditure-of-abbvie-as-revenue-share/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
